Lino Rodrigues

ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-Experienced Patients With HCV Genotype 1b Infection

Pietro Andreoné, Massimo Colombo, Jeffrey Enejosa et al. · Gastroenterology · 2014 · 369 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1–6 and compensated cirrhosis: The EXPEDITION-8 trial

Robert S. Brown, Lino Rodrigues, Vladimir Chulanov et al. · Journal of Hepatology · 2019 · 155 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

Hiromitsu Kumada, Kazuaki Chayama, Lino Rodrigues et al. · Hepatology · 2015 · 153 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Household structure and urban services: neglected targets in the control of visceral leishmaniasis

Carlos Henrique Nery Costa, Guilherme Loureiro Werneck, Lino Rodrigues et al. · Annals of Tropical Medicine and Parasitology · 2005 · 97 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients

Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki et al. · Hepatology · 2015 · 82 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17